Latest News and Press Releases

PRESS RELEASE RESS RELEASE Immunocore presents new data on tebentafusp in metastatic cutaneous melanoma (mCM) and uveal melanoma (mUM) at the Society for Immunotherapy of Cancer (SITC) 36th Annual...

REDWOOD CITY, Calif. and CAMBRIDGE, Mass. , Nov. 09, 2021 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR), a biotechnology company focused on hematopoietic stem cell therapeutics, today...

- In non-clinical models, a single dose of TransCon™ TLR7/8 Agonist activated critical innate and adaptive immune mechanisms, providing sustained modulation of tumor microenvironments with low...

Data from Monotherapy Arms of Ongoing Phase 2 ELX-02 Cystic Fibrosis (CF) Clinical Trials Expected in Fourth Quarter of 2021 Received FDA Fast Track Designation for ELX-02 for the...

LOS ANGELES, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (“Aadi”), clinical-stage biopharmaceutical company focusing on precision therapies for genetically-defined cancers with...

Final Overall Survival (OS) data supports Phase III clinical development of efti in combination with paclitaxel in metastatic breast cancerOS benefit trend in total population, with median survival...

SAN DIEGO, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Founders First Capital Partners (Founders First), the nation’s leading revenue-based finance and advisory investment platform for underserved and...

SACRAMENTO, CA, Nov. 09, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Boon Industries, Inc. (OTC PINK: BNOW) (“Boon” or the “Company”), an innovative bioscience company delivering solutions that...

VANCOUVER, British Columbia, Nov. 09, 2021 (GLOBE NEWSWIRE) -- OOOOO Entertainment Commerce Limited (“OOOOO”) (OOOO: TSXV), a mobile commerce platform, is pleased to announce that Digital-First...

Proceeds to fund continued increases in sales and marketing, software development, and other key drivers of growth San Francisco, Nov. 09, 2021 (GLOBE NEWSWIRE) -- RocketFuel Blockchain, Inc. (OTC...